Comparing the benefits of chemoradiotherapy and chemotherapy for resectable stage III A/N2 non-small cell lung cancer: a meta-analysis

BACKGROUND: Induction chemotherapy has been shown to improve survival of patients with stage III A/N2 (T1–3, N2, M0) non-small cell lung cancer (NSCLC), followed by resection, but the benefits of neoadjuvant radiotherapy still remain controversial. METHODS: PubMed, Embase, and Cochrane library datab...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yuqiao, Peng, Xiong, Zhou, Yuan, Xia, Kun, Zhuang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771204/
https://www.ncbi.nlm.nih.gov/pubmed/29338734
http://dx.doi.org/10.1186/s12957-018-1313-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771204/
https://www.ncbi.nlm.nih.gov/pubmed/29338734
http://dx.doi.org/10.1186/s12957-018-1313-x

Ejemplares similares